MAPT and Alzheimer disease: In particular, the pathological hallmarks of AD, abnormal Aβ and tau aggregates, were identified in the retina of patients with mild cognitive impairment (MCI) and AD, along with vascular changes, inflammation, and neurodegeneration44–76.